Abstract OBJECTIVES: Chest computed tomography (CT) scanning has been widely utilized in thymoma identification and staging as well as in follow-up monitoring for recurrence. However, the relationship between some CT imaging features and pathological types, clinical stage, completeness of resection, or prognosis in thymoma has not been well explored.
INTRODUCTION
Thymoma is the most common primary neoplasm of thymus, but its prognosis varies significantly. It has been well established that some advanced disease may benefit from some neoadjuvant chemotherapy to enable effective resection and prolong survival. These subgroups are better to be identified preoperatively based on the anticipated completeness of resection, the Masaoka clinical stage or even the World Health Organization (WHO) histological classification [1] [2] [3] [4] .
Being in a better spatial resolution and more user-friendly, a computed tomography (CT) scan plays a major role in identifying and characterizing thymoma. The heterogeneity in gross morphology and local invasion results in a variety of radiological appearances. In contrast to other predictors, such as the WHO histological classification, the Masaoka-Koga staging system and the completeness of resection, CT scanning is not only a postoperative evaluation system, but also has a potential application in instructing the treatment strategy especially in a neoadjuvant setting. However, to our knowledge, the significance of CT scans for predicting histological types and tumour aggressiveness has not been well elucidated.
The purpose of this study was to evaluate the association between CT findings and histological types, clinical stage and the completeness of resection of thymoma. The potential role of CT scans in predicting survival in thymoma was also explored.
MATERIALS AND METHODS
We retrospectively reviewed the medical records of the patients who underwent thymoma resection between October 2007 and December 2011. The inclusion criteria for patient selection were as follows: (i) all patients underwent curative-intent operation with pathologically proven thymoma; (ii) no neoadjuvant treatment was performed and (iii) CT imaging was performed within 4 weeks before surgery. Institutional review board approval was granted for this retrospective study along with a waiver of patient consent.
All images were obtained when the patients were in a supine position with suspended inspiration, tomographed on both mediastinal (window width, 400-450 HU; window level, 20-50 HU) and lung (window width, 1000-1500 HU; window level, −650 to −750 HU) windows. Intravenously administered contrast medium was used in most of the patients. Many images were offered with courtesy from other hospitals, so there was lack of a standardized protocol. All slice thicknesses were not more than 10 mm. CT images were assessed on the following parameters: size (the greatest tumour axis diameter), predominant location (left, right or middle), tumour contours (smooth, lobulated or irregular), homogeneity (homogeneous or heterogeneous), attenuation compared with chest wall muscle (lower, equal or higher), calcifications, fat plane obliteration with adjacent structures, mediastinal lymphadenopathy (short-axis diameter >10 mm), irregularity in lung infiltration, irregularity in vessel infiltration, abutment degree of vessel circumference (cut-off, 50%), presence of pulmonary change adjacent to the tumour (opacity of lung field) and tumour shape (round, oval or plaque-like). The shape was classified as round if the long-to shortaxis ratio was less than 1.5, oval if the ratio was equal to 1.5 or greater and less than 3.0 and plaque-like if the ratio was equal to or greater than 3.0. CT images were randomized and then separately reviewed by two readers blinded to the clinical or pathological information except the definite diagnosis of thymoma. Any differences in their findings were resolved by consensus.
Thymoma was classified by the 2004 revised WHO histological classification [5] , which is based on the morphology of epithelial cells and the lymphocyte-to-epithelial cell ratio. The final pathological staging was identified according to the Masaoka-Koga system [6] . The adjuvant treatments following surgical resection in the forms of radiotherapy and/or chemotherapy were administered according to the clinicians' discerns and no standard protocol was followed.
Most patients were followed up at outpatient clinic at 3-month intervals for the first year, 6-month intervals for the subsequent year and yearly for the next 3 years. A physical examination, chest radiography or chest CT were performed during every clinic visit. Upper abdominal ultrasound was also performed if clinically indicated. Survival data that were not available in the medical records have been obtained by phone calls or mailing patients. The overall survival duration was defined as the interval between the operation date and the date of death by any cause, or the last follow-up date. Disease-free survival was the interval from the date of resection to the date of proven detection of recurrence or metastases. All the outcome measures were defined as per the recommendations of the International Thymic Malignancy Interest group (ITMIG) [7] . Recurrence was confirmed by either biopsy or unequivocal evidence of tumour masses (newly appearing metastases or local recurrence) with a tendency to grow during the further follow-up. The last general follow-up of survivors was done at the end of October 2013. All patients were followed up for a median of 37 months (range, 1-71 months).
The χ 2 test was used to verify the association between categorical variables, while continuous variables were evaluated with an unpaired Student's t-test. Overall survival and disease-free survival rates were calculated via the Kaplan-Meier method. Differences in survival duration were evaluated with a log-rank test. The variables were found to be significant on a univariate analysis (defined as a probability value of less than 0.15) and were included in a multivariate analysis, using the Cox proportional hazards model after backward stepwise Wald elimination. A probability value of less than 0.05 on multivariate analysis was considered significant. All statistical analyses were performed with the SPSS V20.0 software (IBM, Chicago, IL, USA).
RESULTS

Clinical features
From October 2007 to December 2011, 417 consecutive thymoma patients in Shanghai Chest Hospital were operated on and pathologicalally confirmed. Among them, 238 patients met the inclusion criteria for the present study. The patients' characteristics are summarized in Table 1 .
Relationship between computed tomography findings and clinical features
The predominant locations were on the left mediastinum in 82 patients (34.5%), on the right in 87 patients (36.6%) and on the Table 2 , CT characteristics were more rigorously associated with the presence of myasthenia gravis (MG) as 6 out of the 13 parameters were identified as statistically significant, followed by the completeness of resection (4/13). 82.1% of MG thymoma patients (111/182), while only 61.0% (46/56) of non-MG thymoma patients, presented a tumour size of less than 7.3 cm (P = 0.003). Location is associated with the presence of MG, being more predominant unilaterally than bilateral (75.8 vs 55.4%, P = 0.013). In addition, more MG patients' tumours demonstrated homogeneous enhancement (MG thymoma versus non-MG thymoma, 66.1 vs 50.3%, P = 0.038), irregular infiltration into the lung (83.9 vs 69.2%, P = 0.031), normal pulmonary imaging appearance adjacent to the tumour (94.6 vs 79.7%, P = 0.009) and plaque-like tumour shape (23.2 vs 8.2%, P = 0.009) in comparison with their counterparts.
In the patients who underwent an incomplete resection, smooth tumour contours presented in 1 of the 117 patients (0.9%), lobulated borders in 6 of the 92 patients (6.5%) and irregular contours in 7 of the 29 patients (24.1%), compared with those of complete resection (P < 0.001). With a cut-off value of 7.3 cm, larger tumour was associated with more heterogeneous enhancement (67.5 vs 35.0%, P < 0.001).
The correlation between CT features and the WHO histological classification is presented in Table 3 . More homogeneous enhancement presented in type B2, whereas more heterogeneous enhancement occured in type AB (P = 0.009). In addition, as to the degree of enhancement, most of the thymomas were equal to the chest wall (155/207, 74.9%), whereas more of the type AB ones presented with thicker than the chest wall (P = 0.013). Although some parameters demonstrated P-value significantly, there were no progressive distribution following the sequence of A, AB, B1, B2 and B3 subtypes.
The association between CT imaging features and the MasaokaKoga clinical stage is summarized in Table 4 . The parameters were listed in an ascending order to the advanced stage, tumour contours, irregular infiltration into the lung and pulmonary changes adjacent to the tumour. Interestingly, we also found that calcifications presented more at the advanced clinical stages (8% in Stage I, 8% in Stage II, 28% in Stage III and 30% in Stage IV, P = 0.002).
Relationship between computed tomography findings and survival duration
Follow-up was complete in 79.0% (188/238) of patients. After the operation, 11 patients (5.9%) received a combination of chemo-and radiotherapy. Seventy-one patients (37.8%) received radiotherapy as the single modality. Four patients (2.1%) underwent chemotherapy alone, and 102 (54.3%) received no adjuvant treatment.
The overall and disease-free 5-year survival rates were 92.2 and 90.1%, respectively. The mean survival duration was 68.4 ± 1.1 months, and the mean time of postoperative recurrence occurred at 66.9 ± 1.3 months after initial surgery.
Fifteen patients (8.0%) had progression after operation. Solo local recurrence was found in 3 patients (20%), regional relapse in 8 (53.3%) and distant metastasis in 4 (26.7%, to liver in 3 patients, bone in 1 and lung in 1). At the conclusion of the study, 173 patients (92.0%) were alive without the evidence of disease (recurrent thymoma), 8 were alive with disease (4.3%) and 7 had died with disease (3.7%). Five patients (2.7%) developed another primary malignancy including leukaemia, oesophageal carcinoma, endometrial carcinoma, hepatic carcinoma or gastric carcinoma.
By univariate analysis, no significant difference in overall survival duration could be identified among various CT image parameters (Table 5 ). Only the presence of pulmonary changes adjacent to the tumour showed a trend to worse disease-free survival (P = 0.052). By multivariate analysis, all CT parameters failed to be an important predictive factor on the overall survival or disease-free survival duration. Heterogeneous enhancement showed a marginal worse impact on disease-free survival duration (P = 0.067; Table 6 ).
DISCUSSION
The objective of this study was to identify which CT findings were associated with the clinical features and prognosis of thymoma. We found that some imaging parameters were really significantly associated with the WHO histological classification, the MasaokaKoga clinical stage and the completeness of resection, but no features of CT imaging could reliably predict either overall survival or disease-free survival duration with our multivariate analysis.
CT scan is the most common imaging modality to evaluate thymoma. There were very limited studies to explore if CT findings were associated with MG in thymoma patients. In this study, we identified that smaller tumour size, predominantly middle location, homogeneous texture, less irregular infiltration into the lung, less pulmonary changes adjacent to the primary tumour and nonround tumour shape were associated with the presence of MG, compared with non-MG thymoma. MG treatment is one of the most important strategies in thymoma therapy, and several patients deceased in emerging MG crisis postoperatively during the follow-up. In the future, based on more case studies and knowledge advanced, a predict model of CT imaging could be developed to instruct clinicians to stratify thymoma patients into subgroups for the most efficient diagnosis and treatment.
In this study, low attenuation areas from cyst formation or necrosis were seen in 109 of 237 thymoma patients (45.6%), with a similar incidence rate to that of another study [8] . Moreover, tumour contours, infiltration of surrounding fat, irregular infiltration into the lung and degree of abutment of vessel circumference were recognized to have a significant relationship with the completeness of resection, which could be utilized to stratify neoadjuvant therapy during clinical practice.
Some studies have shown that CT scanning cannot differentiate the WHO histological subtypes of thymoma [9] [10] [11] [12] . However, we here confirm the sufficiency of CT findings in predicting the WHO 
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histological classification based on tumour contours, homogeneity, degree of enhancement, infiltration of surrounding fat, mediastinal node enlargement, irregular infiltration into the lung and tumour shape. Tomiyama et al. [12] reported that smooth contours and roundness in shape are strong indicators for type A tumour, but CT scanning was of limited value in discriminating their subtypes [9] . In contrast to previous studies [12] , we did not find the correlation between calcification and type B1, B2 and B3 tumours. Marom et al. [13] identified that the only feature that could correlate to the WHO system is tumour size, with a tumour size of ≥7 cm in diameter being greatly considered as B3 disease, which has not been proved by our study.
The following CT parameters that could effectively predict clinical stage preoperatively are listed in an ascending order (to more advanced stages): tumour contours (P < 0.001), presence of calcifications (P = 0.002), irregular infiltration into the lung (P < 0.001) and image changes at the pulmonary fields adjacent to the tumour (P < 0.001). Our study has confirmed the similar studies, which showed that lobulated or irregular tumour contour is a feature to predict more invasive subgroups [8, [13] [14] [15] . Several researchers have also observed that calcifications were more common in an invasive tumour [8, [13] [14] [15] . The difference between our study and others is that no association was found between larger tumours [13] or heterogeneous enhancement [8] and advanced stage disease in this study. Several studies found that the obliteration of fat planes was not helpful in distinguishing noninvasive thymoma from invasive types [8, 14, 15] . Although not following a strict stepwise trend from Stage I to IV, we have shown that the infiltration of surrounding fat suggests an invasive thymoma, confirming the prior studies [13, 16] . We assessed the CT findings in thymoma in order to seek some practical parameters to predict overall survival and disease-free survival durations. Some researchers [17] [18] [19] demonstrated that larger tumours were more likely to recur. In contrast, we showed no correlation found between tumour size and survival rate, consistent with the reports from Elkiran and others [13, 20] . We also confirmed the prior report that no significant differences were found in prognosis in thymoma between with and without calcifications [10] . On the other hand, our study could not validate the previous reports [9, 10] that patients with irregular tumour contours, mediastinal fat infiltration, great vessel invasion or atypical tumour shape experienced more frequent recurrence and metastases significantly.
The limitations, including the variety of utilized scanners and their settings, have to be admitted in this study. Although a prospectively collected database was used, many variables in this study were retrospectively supplemented, making the analyses retrospective. In fact, the very low incidence rate of thymoma has significantly impeded a prospective study into practice. In our study, CT scans were performed in several different hospitals without a standardized protocol to follow. The follow-up period may not be long enough to estimate prognosis in all aspects. Thymoma has a characterized indolent clinical course, and the power to detect the practical associations between CT findings and survival duration is therefore fairly low. In addition, the analysis of a single-institution experience raises the issue of external validity. However, this study population more accurately reflects contemporary clinical management in the last decade and might be more updated than the prior study populations, which dated back for several decades. In summary, the results from this retrospective study of 238 operated thymoma patients indicated that some features of CT imaging were significantly correlated with the WHO classification, the Masaoka-Koga clinical stage and the completeness of resection, even if the CT scanning has no definite role in predicting survival duration of thymoma patients. 
